California utility creates fund for victims of january's deadly eaton fire near la
'Even though the details of how the Eaton Fire started are still being evaluated, SCE will offer an expedited process to pay and resolve claims fairly and promptly,' Pedro Pizarro, chief executive of Edison International, the utility's parent company, said in a statement Wednesday. 'This allows the community to focus more on recovery instead of lengthy, expensive litigation.' It is not clear how much money the utility will contribute to the fund. A lawsuit filed by Los Angeles County in March claims that costs and damage estimates were expected to total hundreds of millions of dollars, with assessments ongoing. SCE said the compensation program, which will go into effect this fall, would be open to those who lost homes, rental properties, or businesses. It would also cover those who suffered injuries, were harmed by smoke, or had family members who were killed.
The LA Fire Justice, which advocates for wildfire victims, said in a statement that the program's creation shows that SCE is prepared to accept responsibility. But the nonprofit said a similar fund by Pacific Gas & Electric following wildfires in Northern California was slow to roll out and inefficient. 'Experience suggests that these direct payments for victims are neither quick nor easy nor equitable. PG&E offered a similar program, and wildfire victims ended up receiving inadequate compensation, and it didn't happen fast,' said Doug Boxer, an attorney for LA Fire Justice. The SCE payment plan is being created by administrators who helped form similar programs, including the September 11th Victim Compensation Fund of 2001. LA County previously won more than $64 million in a settlement with Southern California Edison over the 2018 Woolsey Fire. Investigators determined SCE's equipment sparked that blaze, and the utility also paid more than $2 billion to settle related insurance claims. Utility equipment has sparked some of the deadliest and most destructive fires in state history in recent years. Investigators are also working to determine the cause of the Palisades Fire, which broke out shortly before the Eaton Fire and killed 12 people and destroyed thousands of structures in Los Angeles.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
an hour ago
- Al Arabiya
Federal judge blocks Arkansas law barring pharmacy benefit managers from owning pharmacies in state
LITTLE ROCK, Ark. – A federal judge temporarily blocked on Monday Arkansas' first-in-the-nation law that would have prohibited pharmacy benefit managers from owning pharmacies in the state. US District Judge Brian Miller issued a preliminary injunction against the law restricting pharmacy benefit managers who run prescription drug coverage for big clients that include health insurers and employers that provide coverage. Republican Gov. Sarah Huckabee Sanders signed the restriction into law earlier this year, and it was set to take effect Aug. 5. CVS and Express Scripts had sued the state over the law. The law, Miller wrote, 'appears to overtly discriminate against plaintiffs as out of state companies, and the state has failed to show that it has no other means to advance its interests.' Republican Attorney General Tim Griffin said he respected the court's decision and planned to appeal. Supporters of the Arkansas law have said it's needed because pharmacy benefit managers are forcing independent pharmacies, especially those in rural areas, to close. CVS and Express Scripts in their lawsuits said the restriction would have devastating effects on consumers if it was allowed to take effect. CVS, which ran TV ads urging Sanders to veto the legislation, has said it would have to close its 23 retail pharmacies in the state if the law takes effect. The company said it was pleased with the decision. 'We continue to be focused on serving people in Arkansas and are actively looking to work together with the state to reduce drug prices and ensure access to pharmacies,' CVS said in a statement. Arkansas is among several states where lawmakers have taken up efforts to regulate pharmacy benefit managers.
Al Arabiya
an hour ago
- Al Arabiya
Waymo plans to dispatch robotaxis in Dallas next year as its driverless expansion races ahead
Robotaxi pioneer Waymo has added Dallas to its expanding list of cities where people will be able to request a driverless ride beginning sometime next year in an attempt to further distance itself from rivals still scrambling to catch up in the autonomous race. Dallas will become the second major Texas city where Waymo's robotaxis operate, following the company's move into Austin earlier this year as part of a partnership with ride-hailing leader Uber. Unlike the Austin driverless rides that must be ordered through Uber's app, Waymo will deploy its Dallas robotaxis through its own service and team up with the Avis Budget Group to manage its fleet there. Waymo hasn't set an exact date in 2026 for when its robotaxis will begin cruising through Dallas, which joins Washington D.C. and Miami as cities where the company plans to expand next year. Waymo's robotaxis have already provided more than 250,000 trips in Austin and several other major US cities including Phoenix, San Francisco, Los Angeles, and Atlanta. As the company continues to expand into new cities, it is pulling even further ahead from the rest of the pack trying to launch driverless ride-hailing services. The aspiring rivals include Tesla, which launched a limited robotaxi service in Austin last month as a prelude to what CEO Elon Musk has repeatedly promised will be a nationwide fleet of driverless cars, even as the automaker faces legal challenges questioning the capability of its autonomous technology. Amazon is also aiming to roll out robotaxis in Las Vegas late this year as part of its Zoox self-driving division. And Uber and Lyft have been relying on a variety of partnerships to supplement their fleet of human-driven vehicles with more driverless options. While others are still trying to get their robotaxis out of the starting blocks, it has been nearly five years since Waymo's driverless ride-hailing service made its debut in Phoenix with a technology that began as a secret project within Google in 2009. Waymo spun out from Google in 2016, but the two companies remain tethered under the same corporate parent Alphabet Inc. Waymo is still testing the possibility of bringing its robotaxis to at least two other Texas cities – Houston and San Antonio – while also exploring a potential expansion in San Diego, Boston, and New York. It is also eyeing Tokyo as its first robotaxi market outside the US.
Al Arabiya
2 hours ago
- Al Arabiya
Sarepta will resume gene therapy shipments after fda review of recent patient death
Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients following a brief pause requested by regulators. The Food and Drug Administration said it recommended lifting the hold for young patients with Duchennes muscular dystrophy who are still able to walk. Regulators had requested the pause after the deaths of two older teenagers who were taking the therapy. The FDA also said in a statement it determined that a recently reported death of an 8-year-old boy was unrelated to the therapy. Company shares surged more than 16 percent after the announcement to 13.86 in afterhours trading. The jump is the latest in a series of drastic stock movements triggered by changing fortunes for the company's best-selling product. Elevidys is the first gene therapy approved in the US for Duchennes muscular dystrophy–the fatal muscle-wasting disease that affects boys and young men resulting in early death. It received accelerated approval in 2023 for a narrow range of young patients and was expanded last year for use in older patients including those who can no longer walk. The FDA decision Monday significantly improves Elevidys' sales outlook in the near-term, Jefferies analyst Andrew Tsai told investors in a note after the announcement. 'The street will feel relieved about the situation suggesting meaningful stock upside potential.' Sarepta's therapy has been under scrutiny from regulators after two teenage boys died earlier this year from acute liver injury–a known side effect of the treatment. The FDA then requested a pause in shipments of the drug after the death of a third patient taking a different Sarepta therapy. FDA officials have suggested the company will need to provide new study data on safety to resume Elevidys' use in older patients. 'The FDA will continue to work with the sponsor regarding non-ambulatory patients which remains subject to a voluntary hold following two deaths,' FDA said in its statement.
